Revenue (Tables)

9 Months Ended

Sep. 30, 2021

Disaggregation Of Revenue [Abstract]

Schedule of Product Revenue Based on Product Line and Location

The following table represents the Company’s product revenue based on product line:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
	(in thousands)				(in thousands)
Coronary	$	47,165	$	6,983	$	99,175	$	16,403
Peripheral		17,725		12,337		52,659		27,927
Other		265		270		1,129		743
Product revenue	$	65,155	$	19,590	$	152,963	$	45,073

Coronary product revenue encompasses sales of the Company’s C² catheters. Peripheral product revenue encompasses sales of the Company’s M⁵ and S⁴ IVL catheters. Other product revenue encompasses sales of the Company’s generators and related accessories.

The following table represents the Company’s product revenue based on the location to which the product is shipped:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021		2020
	(in thousands)				(in thousands)
United States	$	52,771	$	11,144	$	116,729	$	24,450
Europe		8,624		6,370		27,266		15,962
All other countries		3,760		2,076		8,968		4,661
Product revenue	$	65,155	$	19,590	$	152,963	$	45,073